Diasol Inc.

Diasol Inc., doing business as Discount Medical Supply, manufactures and supplies hemodialysis acid concentrates and bicarbonate mixture bags to the federal correctional healthcare system as a woman-owned small business prime contractor, with 100% of its recent awards held directly (no subcontracting activity). Based in Phoenix, Arizona, Diasol is a for-profit Subchapter S corporation competing predominantly full-and-open rather than under set-aside vehicles, though the underlying indefinite delivery contract with the Bureau of Prisons Medical Center was originally solicited as a total small business set-aside.

Customer concentration at Diasol is extreme: the Department of Justice Bureau of Prisons Medical Center for Federal Prisoners Springfield accounts for 126 of 132 awards (95.5% of total) and $4.7 million of the $4.8 million combined potential value. The Department of Veterans Affairs Veterans Health Administration operates two small regional nodes — Veterans Integrated Service Network 1 (five awards, $39 thousand) and Veterans Integrated Service Network 4 (one award, $59 thousand) — representing marginal exposure outside the Bureau of Prisons relationship. The vendor's federal footprint is single-customer-dependent.

Diasol operates under two primary indefinite delivery vehicles within the Bureau of Prisons system: Indefinite Delivery Contract DJBP041400000065 (59 task orders, $700 thousand combined potential value) and Indefinite Delivery Contract 15B41420D00000063 (50 task orders, $660 thousand combined potential value), with a third vehicle, Indefinite Delivery Contract 15BFA025D00000023 (13 task orders, $215 thousand combined potential value), capturing the Veterans Affairs work. The current anchor IDC with the Medical Center for Federal Prisoners Springfield, awarded June 1, 2025, carries a $1.336 million ceiling and runs through May 31, 2031, replacing a predecessor contract valued at $907 thousand that operated from April 2020 through March 2025. Monthly delivery orders under the current vehicle range from approximately $15,000 to $25,000 for standardized formulations of acid concentrates in 2K+ and 3K+ formulations and bicarbonate concentrate mixtures supporting dialysis operations at the Springfield facility.

Activity has remained stable across the past five years — eight to eleven awards annually between 2022 and 2025 — with only one award (combined potential value $15 thousand) facing ultimate completion inside the next twenty-four months, indicating minimal near-term recompete pressure. The combined $4.8 million potential value and $1.7 million obligated dollars across 132 awards reflect recurring monthly and quarterly ordering against standing IDCs rather than large-dollar, episodic procurements. Award categorization centers on Pharmaceutical Preparation Manufacturing (74 awards) and Electromedical and Electrotherapeutic Apparatus Manufacturing (52 awards) at the NAICS level, with all 129 primary awards classified under Medical And Surgical Instruments, Equipment, And Supplies (PSC code).

Diasol's federal revenue footprint is narrow and stable: a single-customer relationship with the Bureau of Prisons Medical Center that generates predictable monthly replenishment orders for specialized hemodialysis consumables, with marginal diversification into VA regional medical centers. The vendor holds no parent GWAC seats, GSA Schedule positions, or other multi-agency vehicles; growth opportunity outside the current Bureau of Prisons IDC structure is not visible in the award record.

Dialysis solutions, Hemodialysis acid concentrate, Sodium bicarbonate, Dialysis chairs, dialysis supplies, medical recliners.